New research from Sweden has located that GLP-one agonist drugs utilized to treat diabetic issues and obesity are not likely to increase thyroid cancer threat, as some…They could be helpful supplements to assist weight loss when blended with proper training and nourishment, but some also come with the risk of major or unwanted side effects (one).